Sheldon Hirt
Chairman bei EXINI DIAGNOSTICS AB
Profil
Sheldon Hirt is currently the Chairman at EXINI Diagnostics AB, Director at ei3 Corp., Senior Vice President & General Counsel at Orbia Advance Corp.
SAB de CV.
He previously worked as the Executive Vice President & General Counsel at Progenics Pharmaceuticals, Inc. and Secretary, Senior Vice President & General Counsel at Amneal Intermediate, Inc. Mr. Hirt completed his undergraduate degree at Columbia College (British Columbia) and his graduate degrees at Columbia Law School and Columbia School of International & Public Affairs.
Aktive Positionen von Sheldon Hirt
| Unternehmen | Position | Beginn |
|---|---|---|
| EXINI DIAGNOSTICS AB | Chairman | 01.07.2015 |
| ORBIA ADVANCE CORPORATION, S.A.B. DE C.V. | General Counsel | 17.05.2019 |
ei3 Corp.
 ei3 Corp. Packaged SoftwareTechnology Services ei3 Corp. engages in the design and development of industrial machines. The company was founded by Spencer Cramer in 1999 and is headquartered in Pearl River, NY. | Director/Board Member | - |
Ehemalige bekannte Positionen von Sheldon Hirt
| Unternehmen | Position | Ende |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | General Counsel | 02.09.2016 |
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | General Counsel | - |
Ausbildung von Sheldon Hirt
| Columbia College (British Columbia) | Undergraduate Degree |
| Columbia Law School | Graduate Degree |
| Columbia School of International & Public Affairs | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ORBIA ADVANCE CORPORATION, S.A.B. DE C.V. | Producer Manufacturing |
| Private Unternehmen | 4 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
ei3 Corp.
ei3 Corp. Packaged SoftwareTechnology Services ei3 Corp. engages in the design and development of industrial machines. The company was founded by Spencer Cramer in 1999 and is headquartered in Pearl River, NY. | Technology Services |
EXINI Diagnostics AB
 EXINI Diagnostics AB Packaged SoftwareTechnology Services EXINI Diagnostics AB engages in the research, development, and operation of healthcare software solutions. The company was founded by Lars Edenbrandt, Carsten Peterson, and Karl Astrom on June 18, 1999 and is headquartered in Lund, Sweden. | Technology Services |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
